1h Free Analyst Time
The acute respiratory distress syndrome treatment market is forecasted to grow by USD 1.22 bn during 2023-2028, accelerating at a CAGR of 6.9% during the forecast period. The report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on lung-protective ventilation strategies, advances in precision medicine and biomarker research, and increasing utilization of ecmo therapy.
The acute respiratory distress syndrome treatment market is segmented as below:
By Distribution Channel
- Hospitals pharmacies
- Retail pharmacies
- Online pharmacies
By Route Of Administration
- Oral
- Injection
- Inhalation
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the acute respiratory distress syndrome treatment market covers the following areas:
- Acute respiratory distress syndrome treatment market sizing
- Acute respiratory distress syndrome treatment market forecast
- Acute respiratory distress syndrome treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global acute respiratory distress syndrome treatment market: Air Liquide SA, Athersys Inc., Boston Scientific Corporation, Dragerwerk AG and Co. KGaA, Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic, Nihon Kohden Corp., SCHILLER AG, Sleepnet Corp., Stryker Corp., Vyaire Medical Inc., Smiths Group Plc, ResMed Inc., Hamilton Medical AG, GE Healthcare Technologies Inc., Fisher and Paykel Healthcare Corp. Ltd., Edesa Biotech Inc., and APEPTICO Forschung und Entwicklung GmbH.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing interest in immunomodulatory therapies for ards.'
According to the report, one of the major drivers for this market is the growing focus on lung-protective ventilation strategies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Air Liquide SA
- Athersys Inc.
- Boston Scientific Corporation
- Dragerwerk AG and Co. KGaA
- Getinge AB
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic
- Nihon Kohden Corp.
- SCHILLER AG
- Sleepnet Corp.
- Stryker Corp.
- Vyaire Medical Inc.
- Smiths Group Plc
- ResMed Inc.
- Hamilton Medical AG
- GE Healthcare Technologies Inc.
- Fisher and Paykel Healthcare Corp. Ltd.
- Edesa Biotech Inc.
- APEPTICO Forschung und Entwicklung GmbH
